Literature DB >> 15770927

Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.

Mohammad Zareie1, Anton A van Lambalgen, Piet M ter Wee, Liesbeth H P Hekking, Eelco D Keuning, Inge L Schadee-Eestermans, Dirk Faict, Bart Degréve, Geert-Jan Tangelder, Robert H J Beelen, Jacob van den Born.   

Abstract

BACKGROUND: Glucose-containing peritoneal dialysis fluids (PDF) show impaired biocompatibility, which is related partly to their high glucose content, presence of glucose degradation products, low pH, and lactate buffer, or a combination of these factors. In a rat chronic peritoneal exposure model, we compared effects of an amino acid-based PDF (AA-PDF) with a glucose-containing PDF on the peritoneal microcirculation and morphology.
METHOD: Two groups of rats received 10 mL of either fluid daily for 5 weeks via peritoneal catheters connected to implanted subcutaneous mini vascular access ports. Leukocyte-endothelium interactions in the mesenteric venules were investigated by intravital microscopy. Quantification of angiogenesis and fibrosis and inspection of the mesothelial cell layer were performed by light and electron microscopy.
RESULTS: Daily exposure to glucose-containing PDF resulted in a significant increase in the number of rolling leukocytes in mesenteric venules, whereas instillation of AA-PDF did not change the level of leukocyte rolling. Glucose-containing PDF evoked a significantly higher number of milky spots in the omentum, whereas this response was significantly reduced in animals exposed to the AA-PDF (p < 0.02). Chronic instillation of glucose-containing PDF induced angiogenesis in various peritoneal tissues, accompanied by fibrosis in the mesentery and parietal peritoneum. Quantitative morphometric evaluation of omentum and mesentery showed a clear trend toward less angiogenesis after treatment with the AA-PDF compared to the glucose-containing PDF, which reached statistical significance in the parietal peritoneum (p < 0.04). Instillation of AA-PDF resulted in approximately 50% reduction of fibrosis in the mesentery (p < 0.04) and approximately 25% reduction in the parietal peritoneum (p < 0.009) compared to glucose-containing PDF. Glucose-containing PDF damaged the mesothelial cell layer, whereas the mesotheium was intact after AA-PDF treatment, as evidenced by electron microscopy.
CONCLUSION: Our data in a rat chronic peritoneal exposure model clearly demonstrate reduced immune activation (evidenced by decreased number of rolling leukocytes and decreased induction of omental milky spots) and reduced neoangiogenesis, fibrosis, and mesothelial damage of the peritoneal membrane after treatment with AA-PDF compared to glucose-containing PDF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770927

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  9 in total

Review 1.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

Review 2.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

3.  A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.

Authors:  Caatje Y le Poole; Angelique G A Welten; Piet M ter Wee; Nanne J Paauw; Amina N Djorai; Rob M Valentijn; Robert H J Beelen; Jacob van den Born; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

Review 4.  Pathogenesis and treatment of peritoneal membrane failure.

Authors:  Ramesh Saxena
Journal:  Pediatr Nephrol       Date:  2007-09-21       Impact factor: 3.714

5.  Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis.

Authors:  Thorsten O Bender; Janusz Witowski; Christoph Aufricht; Michaela Endemann; Ulrich Frei; Jutta Passlick-Deetjen; Achim Jörres
Journal:  Pediatr Nephrol       Date:  2008-05-15       Impact factor: 3.714

6.  Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.

Authors:  Valerio Vizzardi; Massimo Sandrini; Silvia Zecchini; Sara Ravera; Luigi Manili; Giovanni Cancarini
Journal:  J Nephrol       Date:  2015-10-31       Impact factor: 3.902

Review 7.  Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.

Authors:  Mufazzal Ahmad; Hemal Shah; Theodori Pliakogiannis; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006-09-27       Impact factor: 2.266

Review 8.  How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease-what can we learn for future treatment?

Authors:  Maria Bartosova; Sotirios G Zarogiannis; Claus Peter Schmitt
Journal:  Mol Cell Pediatr       Date:  2022-05-05

9.  A Novel Mouse Model of Peritoneal Dialysis: Combination of Uraemia and Long-Term Exposure to PD Fluid.

Authors:  E Ferrantelli; G Liappas; E D Keuning; M Vila Cuenca; G González-Mateo; M Verkaik; M López-Cabrera; R H J Beelen
Journal:  Biomed Res Int       Date:  2015-10-26       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.